RCM
CASC

Rotella Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Rotella Capital Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,320
Closed -$97K – 724
2015
Q2 		$97K Buy
+4,320
New +$97K 0.08% 283
2014
Q3 		– Sell
-3,170
Closed -$62K – 445
2014
Q2 		$62K Sell
3,170
-400
-11% -$7.82K 0.05% 291
2014
Q1 		$64K Buy
+3,570
New +$64K 0.08% 151